Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- AdventHealth
- 试验地点
- 1
- 主要终点
- 22 gauge needle
研究概览
简要总结
The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the need to use the 19 gauge needle for core tissue procurement.
详细描述
Inclusion Criteria
- Age under 19 years
- Pregnant women will be excluded. This will be confirmed by self-report
Exclusion Criteria
- Age under 19 years
- Pregnant women will be excluded. This will be confirmed by self-report
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 89 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients who are referred to Florida Hospital Center for Interventional Endoscopy for a EUS FNA for core biopsy (19 gauge needle biopsy) who have needle dysfunction (This occurs in about 10% of patients)
排除标准
- •Age under 19 years
- •Pregnant women will be excluded. This will be confirmed by self-report
研究组 & 干预措施
19 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle.
干预措施: 19 gauge (Procedure)
22 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle.
干预措施: 19 gauge (Procedure)
22 gauge
Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle.
干预措施: 22 gauge (Procedure)
结局指标
主要结局
22 gauge needle
时间窗: 72 hours
Compare the quality of core tissue specimens obtained between a 19G and 22G needle by evaluating the ability to perform molecular marker studies or immunohistochemistry studies between samples obtained.
次要结局
未报告次要终点